Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
4.290
-0.250 (-5.51%)
At close: Oct 31, 2024, 4:00 PM
4.310
+0.020 (0.47%)
After-hours: Oct 31, 2024, 4:51 PM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $269.13 million as of October 31, 2024. Its market cap has increased by 30.90% in one year.
Market Cap
269.13M
Enterprise Value
187.00M
1-Year Change
30.90%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $382.60M to $269.13M, a decrease of -29.66%. That is a compound annual growth rate of -7.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 284.80M | 8.25% |
| Dec 29, 2023 | 263.10M | 520.52% |
| Dec 30, 2022 | 42.40M | -73.73% |
| Dec 31, 2021 | 161.40M | -66.54% |
| Dec 31, 2020 | 482.40M | 26.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kamada | 314.38M |
| Design Therapeutics | 313.11M |
| OraSure Technologies | 310.20M |
| Spok Holdings | 306.80M |
| Treace Medical Concepts | 301.00M |
| AC Immune | 296.82M |
| ADC Therapeutics | 295.86M |
| Delcath Systems | 294.01M |